Therapy News and Research

RSS

Engager Transcatheter Aortic Valve Implantation System pivotal trial to be conducted at 11 European centers

Medtronic, Inc. today announced the start of the Engager European Pivotal Trial to pursue CE Mark for the Engager Transcatheter Aortic Valve Implantation System in patients suffering from severe aortic stenosis.

From Medtronic 28 Sep 2011

Postmenopausal HRT linked with increased risk of asthma hospitalisations in women

Women taking postmenopausal hormone replacement therapy (HRT) may have an increased risk of severe asthma attacks requiring hospitalisation, scientists warn.

28 Sep 2011

Study sheds light on when to start antiretroviral therapy

Findings from a study published in the current issue of the journal Archives of Internal Medicine, when "taken together with other studies published over the last few years," show that beginning people living with HIV on highly active antiretroviral therapy (HAART) when their CD4 cell count is between 350 and 500 "appears to be beneficial over the long term.

28 Sep 2011

Sex therapy for prostate cancer after treatment may improve sex life: Study

Prostate cancer treatments can play havoc with men’s sex lives causing erectile dysfunction and other frustrating problems. For example, a recent study found about 60 percent of men with prostate cancer who had their prostate glands removed had not recovered their sexual function two years after their treatment. Many also lost some desire for sex and had a diminished ability to reach or enjoy orgasms. But new research shows that sex therapy can make a big difference.

27 Sep 2011

Coffee reduces risk of depression in older women: Study

A new study shows that risk of depression decreases as coffee consumption increases. The findings however apply only to post-menopausal women who smoke.

27 Sep 2011

22nd Century completes enrollment in X-22 Phase II-B smoking cessation study

22nd Century Group, Inc., a company focused on smoking cessation and tobacco harm reduction products, announced today that enrollment of its X-22 Phase II-B clinical trial has been successfully completed; 234 smokers have been randomized in the double-blind, active-controlled, multi-center smoking cessation study.

27 Sep 2011

Men with localized prostate cancer benefit from intensity modulated radiation therapy

Men with localized prostate cancer treated with a newer technology, intensity modulated radiation therapy (IMRT), have more than a quarter (26 percent) fewer late bowel and rectal side effects and a statistically improved lower dose of radiation to the bladder and rectum, compared to those who undergo 3D-CRT, according to a randomized study presented at the plenary session October 3, 2011, at the 53rd Annual Meeting of the American Society for Radiation Oncology.

27 Sep 2011

HCRI completes enrollment in dual antiplatelet therapy clinical trial

The Harvard Clinical Research Institute (HCRI) announced today that the enrollment phase of the DAPT Study has been successfully completed. The DAPT Study is a four-year clinical trial investigating the duration of dual antiplatelet therapy (DAPT, the combination of aspirin and a thienopyridine/antiplatelet medication to reduce the risk of blood clots) following drug-eluting stent implantations.

27 Sep 2011

Hospital for Special Surgery establishes HSS Spine & Sport in Jupiter, Florida

Hospital for Special Surgery (HSS), a world leader in orthopedics, rheumatology and rehabilitation, announced the establishment of HSS Spine & Sport in Jupiter, Florida. This first HSS expansion beyond the New York region is a direct response to patient and physician demand.

27 Sep 2011

New Banner MD Anderson center to deliver unprecedented cancer care in Arizona

Banner MD Anderson Cancer Center, a unique collaboration between Banner Health and The University of Texas MD Anderson Cancer Center, opens today, ushering in a new era of unprecedented cancer care in Arizona.

27 Sep 2011

Elevation presents positive data from EP-101 Phase 2a study on COPD at ERS annual meeting

Elevation Pharmaceuticals, Inc., a biopharmaceutical company focused on the development of new aerosol therapies for patients with respiratory diseases, announced today that it presented positive results from a Phase 2a study of EP-101 in patients with moderate to severe chronic obstructive pulmonary disease (COPD), a large and growing disease characterized by significant unmet clinical needs, at the annual meeting of the European Respiratory Society.

27 Sep 2011

Stony Brook University opens new center to treat valvular heart disease

Stony Brook University Medical Center has opened a new Valve Center that offers comprehensive treatment of valvular heart disease.

27 Sep 2011

Novartis files marketing authorisation with EMA for NVA237 to treat COPD

Sosei Group Corporation, today announces that NVA237 (glycopyrronium bromide), a long-acting muscarinic antagonist (LAMA) being investigated as a once-daily treatment for chronic obstructive pulmonary disease (COPD), has been filed by Novartis for marketing authorisation with the European Medicines Agency (EMA), under the brand-name Seebri Breezhaler, triggering a $5m milestone payment to Sosei.

27 Sep 2011

Researchers modify HIV in a way that makes it no longer able to suppress immune system

Researchers at Johns Hopkins have modified HIV in a way that makes it no longer able to suppress the immune system. Their work, they say in a report published online September 19 in the journal Blood, could remove a major hurdle in HIV vaccine development and lead to new treatments.

27 Sep 2011

Data from YM BioSciences' nimotuzumab clinical trials to be reported at ECCO-ESMO 2011

YM BioSciences Inc., a drug development company advancing a diverse portfolio of hematology and cancer-related products, today announced that data from several clinical trials of nimotuzumab are scheduled be reported at the 2011 European Multidisciplinary Cancer Congress (ECCO-ESMO), September 23-27, 2011, in Stockholm, Sweden.

27 Sep 2011

UCSF, QuantiaMD develop new DiabetesIQ mobile phone app

A new interactive mobile phone app called DiabetesIQ, released this week, challenges people to test their knowledge of diabetes and to compete with one another as they learn about the complexities of the disease, which affects more than 25 million Americans, including 4 million Californians.

27 Sep 2011

Zoledronic acid may extend survival in older breast cancer patients

A drug used to protect bone may extend survival in older breast cancer patients, according to researchers at the Universities of Sheffield and Leeds.

27 Sep 2011

Smaller and faster clinical drug trials could improve gains in cancer survival

With the advent of personalised medicine, gains in cancer survival over the long term could be improved by running smaller, faster trials with less stringent evidence criteria, a researcher told the 2011 European Multidisciplinary Cancer Congress.

26 Sep 2011

Pacira announces data from EXPAREL clinical study presented at ASPS 2011 meeting

Pacira Pharmaceuticals, Inc. today announced that the company's lead investigational product for postsurgical pain management, EXPAREL, was highlighted in the "Hot Topics in Plastic Surgery" panel at the annual scientific assembly of the American Society of Plastic Surgeons (ASPS) in Denver, Colo.

26 Sep 2011

World's first treatment of metastasized brain cancer uses IsoRay's Cesium-131 brachytherapy seeds

IsoRay, a medical technology company and innovator in seed brachytherapy and medical radioisotope applications, announced today that doctors at New York Presbyterian Hospital/ Weill Cornell Medical Center have performed the world's first treatment of metastasized brain cancer using IsoRay's Cesium-131 brachytherapy seeds.

26 Sep 2011

Therapy News and Research

Engager Transcatheter Aortic Valve Implantation System pivotal trial to be conducted at 11 European centers

Postmenopausal HRT linked with increased risk of asthma hospitalisations in women

Study sheds light on when to start antiretroviral therapy

Sex therapy for prostate cancer after treatment may improve sex life: Study

Coffee reduces risk of depression in older women: Study

22nd Century completes enrollment in X-22 Phase II-B smoking cessation study

Men with localized prostate cancer benefit from intensity modulated radiation therapy

HCRI completes enrollment in dual antiplatelet therapy clinical trial

Hospital for Special Surgery establishes HSS Spine & Sport in Jupiter, Florida

New Banner MD Anderson center to deliver unprecedented cancer care in Arizona

Elevation presents positive data from EP-101 Phase 2a study on COPD at ERS annual meeting

Stony Brook University opens new center to treat valvular heart disease

Novartis files marketing authorisation with EMA for NVA237 to treat COPD

Researchers modify HIV in a way that makes it no longer able to suppress immune system

Data from YM BioSciences' nimotuzumab clinical trials to be reported at ECCO-ESMO 2011

UCSF, QuantiaMD develop new DiabetesIQ mobile phone app

Zoledronic acid may extend survival in older breast cancer patients

Smaller and faster clinical drug trials could improve gains in cancer survival

Pacira announces data from EXPAREL clinical study presented at ASPS 2011 meeting

World's first treatment of metastasized brain cancer uses IsoRay's Cesium-131 brachytherapy seeds

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News